Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THUMP domain containing 3 pseudogene 1 (THUMPD3P1) is classified as a pseudogene, meaning it is a DNA sequence similar to a protein-coding gene (in this case, the THUMPD3 gene encoding a tRNA guanosine methyltransferase[4]), but harbors mutations or deletions that render it non-coding and unable to produce functional protein[3][5]. Most pseudogenes do not encode proteins but can be transcribed into RNA, and in some cases, pseudogene transcripts have been shown to regulate the expression of their parental genes or participate in RNA networks, often by acting as microRNA decoys or sources of non-coding RNAs, potentially impacting cellular functions and disease biology[5]. There is no evidence that THUMPD3P1 acts as a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), nor is there evidence of any drugs interacting with it or clinical biomarker relevance. No evidence suggests incorrectness in the naming or basic identity of this gene, but as a pseudogene, it does not exert direct protein-mediated biological effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THUMP domain containing 3 pseudogene 1 (THUMPD3P1).